Correlation Between Cigna Corp and Neuropace

Can any of the company-specific risk be diversified away by investing in both Cigna Corp and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cigna Corp and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cigna Corp and Neuropace, you can compare the effects of market volatilities on Cigna Corp and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cigna Corp with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cigna Corp and Neuropace.

Diversification Opportunities for Cigna Corp and Neuropace

-0.52

Correlation Coefficient

Cigna Corp  Neuropace

Excellent diversification

The 3 months correlation between Cigna and Neuropace is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Cigna Corp and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Cigna Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cigna Corp are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Cigna Corp i.e., Cigna Corp and Neuropace go up and down completely randomly.

Pair Corralation between Cigna Corp and Neuropace

Allowing for the 90-day total investment horizon Cigna Corp is expected to under-perform the Neuropace. But the stock apears to be less risky and, when comparing its historical volatility, Cigna Corp is 2.61 times less risky than Neuropace. The stock trades about -0.17 of its potential returns per unit of risk. The Neuropace is currently generating about 0.16 of returns per unit of risk over similar time horizon. If you would invest  722.00  in Neuropace on September 23, 2024 and sell it today you would earn a total of  431.00  from holding Neuropace or generate 59.7% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Cigna Corp  vs.  Neuropace

Cigna Corp

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Cigna Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Neuropace

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cigna Corp and Neuropace

The main advantage of trading using opposite Cigna Corp and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cigna Corp position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.

The idea behind Cigna Corp and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.